Our Cancer Play Approved by the FDA! Here’s What’s Next for This 200% Gainer. Plus, an Update on Our October Rare Disease Pick

Something big just happened with one of our recommendations. We entered this position well ahead of the recent good news from the FDA, and it has held steady near a gain of 200% since it spiked in mid-July

The post Our Cancer Play Approved by the FDA! Here’s What’s Next for This 200% Gainer. Plus, an Update on Our October Rare Disease Pick appeared first on Agora Financial.